New drug combo shows promise in shrinking cervical tumors before surgery
NCT ID NCT07286253
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a new drug called QL1706, given with chemotherapy, before surgery for women with locally advanced cervical cancer. The goal is to shrink tumors enough to allow complete removal. About 50 women will take part. The main focus is on whether the cancer disappears entirely in the removed tissue.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NEOADJUVANT TREATMENT FOR LOCALLY ADVANCED CERVICAL CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Lipai Chen
RECRUITINGGuangzhou, Guangdong, China